Description
Ensartinib, sold under the brand name Ensacove, is an anti-cancer medication used for the treatment of non-small cell lung cancer. Ensartinib is an anaplastic lymphoma kinase inhibitor used as the salt ensartinib hydrochloride.
The most common adverse reactions include rash, musculoskeletal pain, constipation, cough, pruritis, nausea, edema, pyrexia, and fatigue.
ENSACOVE (ensartinib) capsules, for oral use Initial U.S. Approval: 2024
Get Assistance for ENSACOVE Import
Need urgent access to ENSACOVE? We’re here to help.
- Expert support for documentation & approvals
- Fast-track import coordination
- End-to-end patient assistance
Call Now | Enquire Today | WhatsApp Support Available
Contact Sourcing Facilitation Team
Contact Name: Mr. Tarun Garg
Address: 60/4, Yusaf Sarai, Near Indian Oil Corp., New Delhi – 110 016 (India)
Mobile/WhatsApp. 9891296838.
Email: support@southdelhipharma.com, southdelhipharma@gmail.com
NEWS / UPDATES
Get Access To ENSACOVE (ensartinib) In India
In India, access is facilitated through a legally compliant Named Patient Program (NPP), as per guidelines from the Central Drugs Standard Control Organization. This ensures safe and regulated import of the medicine for individual patients. Brand Name “ENSACOVE” or Generic Name “ensartinib” can be imported for personal use under “Named Patient Program” treatment in in Delhi, Mumbai, Kolkata, Chennai, Bangalore, Hyderabad, Ahmedabad, Pune, Surat, Jaipur, Coimbatore, Noida, Gurgaon (Gurugram), Punjab, Chandigarh, Bhubaneswar, Arunachal Pradesh, Assam, Manipur, Meghalaya, Mizoram, Nagaland, Tripura and Sikkim, Noida, Kanpur, Lucknow, Dehradun, Shimla India.. Contact us at support@southdelhipharma.com, southdelhipharma@gmail.com or call/WhatsApp at +91-9891296838 to get access as per norms.
Note: South Delhi Pharma, act as a facilitation partner and do not manufacture, sell, or distribute pharmaceutical products. All facilitation activities are conducted in accordance with applicable Indian pharmaceutical and trade regulations.





